Altamira Therapeutics Ltd. Adjustments For Finance Costs
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Finance Costs of CHF 520.13 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceCosts · last filed 2019-03-14
| Period end | Adjustments For Finance Costs 12 month |
|---|---|
| 2018-12-31 | 520.13K CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 1.03M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |